Advantis Corporation (OTCMKTS:ADVT) Reports Record Quarterly Revenue


Advantis Corporation (OTCMKTS:ADVT) shares were up 1.33% to $0.0152 and flat in after-hours trading on Monday. The company has a market cap of $6.98 million at 465.48 million shares outstanding. Share prices have been trading in a 52-week range of $0.00 to $0.04.

Advantis Corporation is a company that focuses on the development of innovative products that supply the medical cannabis, research, and pharmaceutical industries. The company is focused on helping people take control of their health and pain management needs. By creating strategic partnerships with innovative companies in the nutraceutical and alternative health care industries, the company is uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals.

In a press release, Advantis Corporation shared that it achieved its highest quarterly revenue in company history at $119,000 in Q1. “This is not just our highest revenue quarter ever,” said CEO Christopher Swartz. “This quarterly revenue dwarfs the annual revenue of any of our previous years. I could not be more proud of the results our team is achieving.”

“We dealt with some adversity this year with our rosin press deal, so we decided to shift gears and make our own press. This adversity was really a blessing; it set the table for us to continue increasing revenue quarter over quarter with a higher margin proprietary product,” Swartz continued.

In the previous year, Advantis Corporation adjusted their business plan to incorporate test runs of Amstercans then added the Nugsmasher line of rosin presses, which promised to significantly increase revenue. According to Swartz, the rosin press brand is currently being tested and will be launched shortly.

“While I am so proud of the numbers we report today, there is more work to do. I fully expect revenue to surge when we introduce it to the market and through our current product pipeline,” he explained. The rosin press is the highest revenue product, but the Amstercans side of the business is showing increasing volume and growth.

“We have an established client base and product pipeline, acquire new relationships daily, and continually develop innovative products. An effective business plan is being executed upon, and today’s quarterly report is the signpost that truly marks the beginning of our upward trajectory,” Swartz concluded.


Previous articleDragon’s Tale Rewards You to Hang Out at the Bar
Next articleEntertainment Gaming Asia Inc. (NASDAQ:EGT) is Attracting Smart Money
With an upbringing rooted in deep ethical values, Yashu Gola knows how to put honesty and dedication into his articles. This young and dynamic financial analyst has done his graduation in IT engineering. His interests in financial writing have once brought him to our digital doorsteps. Since then, he has been an integral part of and writes the most captivating news-articles on the foreign exchange industry, cryptocurrencies, and medical marijuana trading.